AKT1 and gastric cancer: The Yi-qi-hua-yu-jie-du Decoction (YJD) enhanced the survival of patients with GC by inhibiting the phosphorylation cascade in the AKT/GSK3β pathway and downregulating Nrf2 expression [52].